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 INTRODUCTION 
 It has been reported that anal fi ssure (AF) is present in about 
10 – 15 % of proctologic patients ( 1 ). Th e clinical hallmark of AF 
is pain during and aft er defecation; rectal bleeding is very oft en 
present as fresh red blood seen on the toilet tissue. 
 Treatment of AF consists of a trial of fi ber supplementation, 
increased volume of daily drinks, sitz baths, and topical analge-
sics ( 2 ); however, most patients remain symptomatic aft er this 
treatment and, consequently, surgery is performed, usually a lat-
eral internal sphincterotomy ( 3 ). It has been demonstrated that 
resting anal pressure is elevated in fi ssure patients ( 4 – 6 ) and this 
could therefore diminish perfusion pressure to the anal tissue 
and lead to ischemic ulceration. For these reasons, a number 
of novel, nonsurgical therapeutic options have been used suc-
cessfully ( 2,6,7 ), including glyceryl trinitrate ( 8 ), diltiazem ( 9 ), 
nifedipine ( 10 ), and botulin toxin ( 11 ), as well as other drugs. 
 In previous works, we have demonstrated that chronic con-
stipation in children can be due to food hypersensitivity (FH) 
( 12 – 14 ), and this has also been demonstrated in a few adult cases 
( 15 ). One of the pathological mechanisms of constipation due to 
FH is the high resting anal pressure, which normalizes on elimi-
nation diet ( 16,17 ), thus demonstrating a relationship between 
the elimination diet and the resting anal pressure. 
 On this basis, we hypothesized that a percentage of adult 
patients suff ering from AF, including both subjects with consti-
pation and those with normal bowel habit or diarrhea, could have 
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a high resting anal pressure due to an unrecognized FH, and this 
study was designed to evaluate this hypothesis. Th e aims of the 
present study were (1) to evaluate the eff ectiveness of an oligo-
antigenic diet in the treatment of chronic AFs (CAFs) and (2) to 
search for a possible cause – eff ect relationship between the diet 
and the onset of the AF. 
 METHODS 
 We enrolled consecutive adult patients with CAF, who were 
referred to the Surgical Department at the University of Palermo, 
between January 2003 and July 2005. In this way, 223 patients 
were initially examined as outpatients. 
 CAF was defi ned as a fi ssure  that was persistent for more than 6 
weeks, with visible transverse internal anal sphincter fi bers at the 
bases of the fi ssure and indurate edges. 
 Inclusion criteria were evidence of CAF evaluated by an 
experienced rectal surgeon and patients aged   >  16 years. 
Exclusion criteria were a diagnosis of infl ammatory bowel dis-
ease, previous anal surgery or trauma, celiac disease or lactose 
intolerance, an ongoing steroid treatment performed for any 
reason, an exclusion diet followed for any reason, and preg-
nancy. An ileum colonscopy was performed on all subjects to 
exclude an infl ammatory bowel disease; the H2-breath test aft er 
50  g of oral lactose load was also performed to exclude lactose 
intolerance. 
 At the time of the fi rst evaluation, a detailed clinical his-
tory with particular attention to the patients ’ bowel habit was 
obtained, and routine laboratory tests, immunology tests, rectal 
biopsies, and anal – rectal manometry were performed. During 
a 2-week prestudy period, the patients ’ bowel movements were 
recorded; constipation was defi ned as less than three evacuations 
per week. 
 Study design 
 Th e study has two diff erent parts .  First part . Th e aim of the fi rst 
part of the study was to verify the eff ectiveness of the oligo-
antigenic diet in CAF treatment. Th e end point of this part of 
 the study was the percentage of cured patients who were given 
an oligoantigenic diet compared with patients who were given a 
 “ normal ” diet. 
 For 8 weeks, all patients received a treatment with sitz baths 
and bran supplementation (20  g of unprocessed bran daily), plus 
topical application of nifedipine 0.3 % and lidocaine 1.5 % cream 
three times daily. No other medications for the anal pain were 
allowed. Furthermore, patients were assigned randomly, and 
with a double-blind method, to one of the two dietary treat-
ment groups: Group A was treated with a  “ sham diet ” based on 
the elimination of rice, potato, lamb, bean, and peas; Group B 
received a  “ true-elimination diet ” based on the elimination of 
cow ’ s milk and its derivatives, wheat, egg, tomato, and choco-
late. Th ese elimination diets were arbitrarily chosen on the basis 
of our previous experience ( 14,18,19 ), as the foods eliminated 
in Group A were almost always tolerated, whereas the foods 
eliminated in Group B were those that most frequently caused 
symptoms in subjects with chronic constipation due to FH. Th e 
patients kept a dietary diary, and adherence to the elimination 
diet was evaluated by trained dieticians. 
 During the study period, the patients were evaluated every 
2 weeks for CAF persistence or healing, by three authors una-
ware of the kind of diet they were undergoing; anal pain was 
scored on a visual analog scale ranging from 0 (absence of pain) 
to 10 (intolerable pain). Furthermore, the number of bowel 
movements per week was recorded. Lateral internal sphinctero-
tomy was off ered to all patients who were not cured by medical 
treatment. 
 Second part . Th e aim of the second part of the study was to 
search for a possible cause – eff ect relationship between the diet 
and the onset of the AF. Th e end point of this part of the study 
was to verify whether the cow ’ s milk proteins and / or the fl our, 
administered according to a double-blind method, could cause 
AF recurrence. 
 At the end of the treatment period, the untreated patients of 
Group A ( “ sham diet ” ) were off ered the  “ true diet ” for 8 weeks, 
before potential surgery. Th ose who accepted and were treated 
with this regimen, and all the patients of Group B, who were cured 
aft er receiving the  “ true elimination diet, ” underwent double-blind 
placebo-controlled (DBPC) challenges for cow ’ s milk and for 
wheat. During this period, the patients continued to avoid wheat, 
cow ’ s milk, egg, tomato, and chocolate. Th e cow ’ s milk challenge 
was performed before or aft er the wheat challenge, aft er rand-
omization. DBPC for cow ’ s milk was performed by administering 
capsules coded as A or B, containing milk proteins (casein from 
bovine milk, lactoalbumin, and lactoglobulin — daily dose 6  g, 
equal to about 200  ml of cow ’ s milk) or xylose, respectively. Six 
capsules were  given daily, which were subdivided three times 
daily, but not with meals. 
 DBPC for wheat protein was performed with capsules 
coded as C or D, containing flour (daily dose 12  g) or xylose, 
respectively. A total of 12 capsules were given daily, which 
were subdivided three times daily, but not with meals. 
Capsules A or B were given for 2 consecutive weeks, and then 
after 4 weeks of washout the patients received the other cap-
sules for another 2 weeks. After 4 weeks of washout, capsules 
C or D were given for 2 consecutive weeks, then after another 
4 weeks of washout the patients received the other capsules 
for 2 weeks. 
 FH diagnoses were based exclusively on the reappearance of 
painful defecation and AFs on food challenge, and its subsequent 
disappearance on an elimination diet. Anal – rectal manometry 
was repeated, both before and on the last day of the cow ’ s milk 
protein challenge period. 
 At least 8 weeks aft er the DBPC challenge periods, open 
oral-food challenges were performed by reintroducing egg, 
tomato, and chocolate; these foods were reintroduced singly 
every 2 weeks. 
 All patients were invited to continue the follow-up, with regular 
visits every 6 months for 4 years.  Figure 1 shows the two parts of 
the study design. 
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 Anal – rectal manometry 
 Manometry was performed with bowel preparation, when 
required, using an open perfuse catheter; sedation was not 
necessary. Th e catheter had a 4.8-mm external diameter and 
three radial ways with bearing point. It was supplied with water 
by a nitrogen infusion pump, and rectal distension was  produced 
223 Elegible patients suffering
from chronic anal fissure
161 Enrolled patients
80 Group A (“sham
diet”) patients
81 Group B (“true
elimination diet”) patients
62 Excluded patients
- 15 For lactose intolerance
- 11 For inflammatory bowel disease
- 5 For celiac disease
- 22 On steroid treatment performed for any reasons
- 3 On oligoantigenic diet followed for any reasons
- 6 Pregnancy
36 Cured patients
10 Uncured patiens accepted “true
elimination diet” for 8 weeks
44 Uncured patients 56 Cured patients 25 Uncured patients
34 Uncured patients
4 Cured patients 6 Uncured patients
All patients cured on “true elimination diet” (Group A + B)
Group A:
4 cured patients
DBPC challenge with cow’s milk and
wheat, cotinuing to avoid cow’s milk
and its derivatives, wheat, egg,
tomato, and chocolate
Open oral food challenges reintroducing in
the diet egg, tomato, and chocolate
Follow-up with visits
every 6 months for 4 years
No Anal Fissures
recurrence on
elimination diet
15 Cases of Anal Fissures
recurrence on
normal diet
6 Positive patients to egg,
2 Positive patients to tomato,
2 Positive patients to chocolate
Group 1:
13 DBPC-positive patients:
7 to both cow’s milk and wheat,
6 to cow’s milk alone
Group 2:
47 DBPC-negative patients
Group B:
56 cured patients
Group A + B:
60 cured patients
Surgical
treatment
 Figure 1 .  Study design and main results of the fi rst and second part of the study. 
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 Aft er beginning the medical and dietary treatments, the patients 
receiving the  “ true-elimination diet ” (Group B) showed a signifi -
cantly higher rate of CAF healing than those receiving the  “ sham 
diet ” (Group A) from the fourth week of treatment. At the end of the 
study , 69 % of Group B and 45 % of Group A patients showed com-
plete healing of CAF ( P  =  0.0002;  Table 2 ). Furthermore, patients 
receiving the  “ true diet ” showed a signifi cantly higher number of 
evacuations per week than those receiving the  “ sham diet ” from the 
fourth to eighth week of treatment. Th e evaluation of the dietary 
diary showed patients ’ compliance to the diet in both groups. 
 Th e 44 uncured patients of Group A, who had received the 
 “ sham-elimination diet, ” were off ered the treatment option of 
with a compliant, distending rectal balloon attached to the 
end of the catheter. Data were recorded by an autocalibrat-
ing polygraph (Narco Bio System  MMS 200) connected to a 
computer with dedicated soft ware for automatic analysis of the 
acquired data. In all patients, data recording was begun 5 – 10  min 
aft er catheter positioning. Anal sphincter resting pressure was 
measured at the end of the manometry procedure and was 
calculated as the mean of a 3-min period. 
 According to the reference values of our laboratory, derived 
from anal – rectal manometry data in healthy subjects, anal 
sphincter resting pressure between 45 and 70  mm  Hg was consid-
ered normal. Th e medical staff s who performed the anal – rectal 
manometry were unaware of the clinical and laboratory data 
of the patients, including the response to the elimination diet, 
histology data, and the immunology study. 
 Histology study 
 All patients underwent rectoscopy with random biopsies. 
Endoscopy and histology methods have been described pre-
viously ( 14 ). Th ree to fi ve biopsies were taken. Intraepithelial 
lymphocytes (normal limit in our laboratory:   <  70 lym-
phocytes / 10 high-power fi eld  × 40) and eosinophil infi ltration 
of the lamina propria (normal limit in our laboratory   <  60 
eosinophils / 10 high-power fi eld  × 40) were evaluated. 
 Statistical analysis 
 Statistical analysis was carried out using the  χ 2 -test for clinical 
outcomes; the Mann – Whitney test for intergroup comparison 
and the Wilcoxon test for intragroup comparison were used 
for data showing a nonGaussian distribution. To determine the 
advantage of  “ true-elimination diet ” over  “ sham diet ” in CAF 
treatment in the fi rst part of the study, power calculation was 
made based on 80 % power and a signifi cance level of  P  <  0.05, 
assuming a success rate in  “ true-elimination diet ” and  “ sham 
diet ” of 80 % and 55 % , respectively. A  P -value of less than 0.05 
was considered statistically signifi cant. 
 Th e study was conducted in accordance with the principles 
of the Declaration of Helsinki (World Medical Association 
Declaration of Helsinki 1989) and Good Clinical Practice (Euro-
pean Agency for the Evaluation of Medicinal Products 2002). 
Th e Ethics Committee of the University Hospital of Palermo 
approved the study, and all patients gave their informed consent 
to participate. 
 RESULTS 
 First part of the study 
 One hundred and sixty one patients were included and ran-
domized to one of the treatment groups and 62 patients were 
excluded ( Figure 1a ).  Table 1 shows the characteristics of the 
patients of each group; constipation was very frequent in both 
groups. Hemoglobin levels, white blood cell count, serum C reac-
tive protein, and erythrocyte sedimentation rate were normal 
in all patients. Th e evaluation of the dietary diary showed a full 
adherence to the elimination diet in both groups. 
 Table 1 .  Patient characteristics in Group A (sham-elimination 
diet) and in Group B (true-elimination diet) 
 
 Group A 
( n =80) 
 Group B 
( n =81)  P value 
 Age (median and range)  38 years 
(18 – 52) 
 36 years 
(18 – 54) 
 Not signifi cant 
 Sex  30 M / 50 F  28 M / 53 F  Not signifi cant 
 Symptom duration 
(median and range 
in months) 
 12 (8 – 24)  12.5 (7 – 28)  Not signifi cant 
 Pain score (VAS)  7.2 ± 2.4  6.9 ± 2.3  Not signifi cant 
 Bleeding  60 (75 % )  57 (70 % )  Not signifi cant 
 Site of fi ssure 
 Posterior midline  72 (90 % )  74 (92 % )  Not signifi cant 
 Anterior midline  8 (10 % )  7 (8 % )  
 Mean ( ± s.d.) anal 
sphincter resting pressure 
(mm  Hg) 
 88 ± 10  90 ± 11  Not signifi cant 
 Coexistent constipation 
(number of cases) 
 70 (87 % )  68 (84 % )  Not signifi cant 
 Coexistent hemorroids 
and / or rectal prolapse 
 45 (56 % )  50 (62 % )  Not signifi cant 
 Multiparity  25  26  Not signifi cant 
 Rectal histology 
  Median (range) IEL 
number 
 30 (10 – 120)  33 (10 – 100)  Not signifi cant 
  Median (range) lamina 
propria eosinophils 
number 
 20 (11 – 90)  22 (10 – 85)  Not signifi cant 
 Immunology data 
  Number of patients with 
positive-specifi c IgE 
 4 (5 % )  6 (7 % )  Not signifi cant 
 F, female; IEL, intraepithelial lymphocyte; IgE, immunaglobin E; M, male; 
VAS, visual analog score. 
 Notes: Constipation was defi ned as the presence of two or more of the follow-
ing: (a) straining during defecations, (b) lumpy or hard stools, (c) sensation of 
incomplete evacuation, (d)   <  3 evacuations per week. 
 Intraepithelial lymphocytes and lamina propria eosinophils were counted in 
10 high-power fi eld — 40 × (IEL normal limits   <  70 lymphocites; eosinophil 
normal limit   <  60). Normal limits for anal sphincter resting pressure were 
between 45 and 70  mm  Hg. 
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of these patients reacted on placebo administration. An identi-
cal clinical reaction was seen during the wheat challenge in the 
seven patients who reacted to the wheat, and four of them did 
not complete the challenge with the  “ active food ” because of AF 
recurrence. 
 During the 4-week washout periods, between the administra-
tion of capsules A or B, or between capsules C or D, all patients 
became asymptomatic again; they underwent the same medical 
and dietary treatment — with the  “ true oligo-antigenic diet ” —
 described for the fi rst part of the study. AFs disappeared in all 
patients and defecation was painless. Similarly, it also happened 
between cow ’ s milk and wheat challenges. 
 Figure 2 shows the mean visual analog score of painful defeca-
tion before and during the 2-week period of the cow ’ s milk chal-
lenge. From the fi rst week, the patients who reacted to the challenge 
showed a signifi cantly higher visual analog score than the patients 
who did not react to the challenge. 
 Table 3 shows the anal sphincter resting pressure, before and 
at the end of the cow ’ s milk challenge, and the rectal mucosa 
histology data. At the end of the challenge, anal sphincter resting 
pressure signifi cantly increased in the patients who showed AF 
reappearance ( P  <  0.0001; Wilcoxon ’ s rank sum test), compared 
with the baseline values, whereas no diff erence was observed in 
the patients who did not react to the challenge. 
 Regarding the rectal mucosa histology, the evaluation per-
formed at the time of entry (fi rst part of the study) showed that the 
patients who reacted to the challenges had a signifi cantly higher 
number of eosinophils in the lamina propria ( z  =  17.7,  P  <  0.0001, 
Mann – Whitney ’ s test) and intraepithelial lymphocytes ( z  =  23.1, 
the  “ true-elimination diet ” before undergoing surgery; 10 of 
them accepted and 34 refused. Of the former 10 patients, 4 
showed complete CAF healing within 8 weeks of dietary treat-
ment. 
 In summary, 65 of the 161 (40 % ) patients remained uncured at 
the end of the study and underwent surgery treatment (a lateral 
internal sphincterotomy). 
 Second part of the study 
 Sixty patients participated in this part of the study: 56 with 
healed CAF on true elimination diet (Group B), plus 4 patients 
of Group A, who had the  “ true-elimination diet ” at the end of 
the fi rst part of the study ( Figure 1b ). Th e subjects consisted 
of 24 men and 36 women, median age 35 years (range 18 – 50 
years). Th ey continued on elimination diet and did not receive 
any medical treatment for CAF during this part of the study. 
Twenty-eight subjects were randomized to the cow ’ s milk 
challenge fi rst and 32 subjects to the wheat challenge. 
 Seven patients were positive for both cow ’ s milk and wheat 
protein challenges, and six were positive only for cow ’ s milk 
challenge. In total, 13 patients were positive for DBPC food 
challenges. 
 In all the patients positive for the cow ’ s milk DBPC chal-
lenge, painful defecation reappeared aft er a median period of 
4 days (range 1 – 8 days), aft er commencing the challenge with 
cow ’ s milk or wheat proteins. AFs reappeared in all 13 patients 
within the 2-week challenge periods: median time 8 days. Ten 
of these 13 patients did not complete the cow ’ s milk challenge 
period with the  “ active food ” because of AF recurrence. None 
 Table 2 .  Part 1 of the Study 
  Cured at 2 weeks  Cured at 4 weeks  Cured at 6 weeks  Cured at 8 weeks 
 Group A  5 / 80 (6 % )  24 / 80 (30 % )  30 / 80 (37 % )  36 / 80 (45 % ) 
 Group B  12 / 81 (15 % )  42 / 81 (52 % )  49 / 81 (60 % )  56 / 81 (69 % ) 
 χ 2 and  2.4  7  8.5  9.5 
 P value  0.12  0.01  0.003  0.003 
  Pain score at 2 weeks  Pain score at 4 weeks  Pain score at 6 weeks  Pain score at 8 weeks 
 Group A  5.1 ± 3.5  4.8 ± 3.4  4.4 ± 3.2  3.6 ± 3.4 
 Group B  4.2 ± 4.0  3.4 ± 3.1  3.0 ± 3.1  2.4 ± 3.3 
 P value  Not signifi cant  0.004  0.008  0.04 
  Bowel movements per week 
at 2 weeks 
 Bowel movements per week 
at 4 weeks 
 Bowel movements per week 
at 6 weeks 
 Bowel movements per week 
at 8 weeks 
 Group A  2.0 ± 1.5  3.0 ± 2.0  3.3 ± 1.9  3.6 ± 1.8 
 Group B  2.4 ± 1.5  3.86 ± 1.6  4.21 ± 1.3  4.55 ± 0.8 
 P value  Not signifi cant  0.005  0.001  0.0001 
 CAF, chronic and fi ssure; VAS, visual analog score. 
 Number and percentage of patients cured (complete healing of CAF), pain score on VAS (mean ± s.d.), and number of bowel movements per week (mean ± s.d.), during 
medical and dietary treatment, in Group A ( n =80) receiving the  “ sham diet ” and in Group B ( n =81) receiving the  “ true diet ” . 
 Note: The number of bowel movements of each patient was recorded every week. 
The American Journal of GASTROENTEROLOGY  VOLUME 108 | MAY 2013   www.amjgastro.com
830
 C
O
LO
N
/S
M
A
LL
 B
O
W
E
L 
 Carroccio  et al. 
 P  <  0.0001, Mann – Whitney ’ s test) than those who did not react to 
the challenges. Specifi c IgE for food antigens were found elevated 
at the time of entry (fi rst part of the study) in 2 of the patients 
who reacted positively to the challenges (2 / 13, 15 % ) and in 2 of the 
patients who did not react (2 / 47, 4 % ; not signifi cant). 
 Th e 13 patients with positive DBPC challenges to cow ’ s milk 
and / or wheat proteins were diagnosed with FH. In these patients, 
open challenges showed hypersensitivity to other foods: egg 
(six cases), tomato (two cases), and chocolate (two cases); the 
ingestion of these foods caused painful defecation and the appear-
ance of AF. 
 Out of the whole group of 161 patients with CAF, 13 sub-
jects (8 % ) had a fi nal diagnosis of FH, and in these subjects 
a causal relationship between FH and CAF was demonstrated. 
Th e percentage of FH causing AF, among the patients who 
received medical treatment plus elimination diet, was 22 % 
(13 / 60 patients). 
 During the 4-year follow-up period, all patients with AF due to 
FH continued to consume an elimination diet, and none of these 
13 patients experienced recurrence of AF. Among the other 47 
patients who suff ered from AF, which was not due to FH, there 
were 15 cases of AF recurrence (32 % ;  P  <  0.05). 
 Among the 65 patients who underwent surgery, there were six 
cases of AF recurrence (9 % ) and fi ve cases of incontinence (7 % ). 
 DISCUSSION 
 In previous studies, we demonstrated that FH could cause 
chronic constipation in children and adults ( 12,13,15 ). In 
these patients, the anal resting pressure is higher than in sub-
jects with chronic constipation, which was not due to FH, and 
it became normal on oligo-antigenic diet ( 16 ). Borrelli  et al. 
( 17 )  demonstrated that mast cell density in the rectal mucosa 
correlates with anal motor abnormalities and the diet positively 
infl uenced this aspect. 
 On this basis, we designed this DBPC prospective study in adults 
with CAFs, as it is known that an elevated anal resting pressure in 
fi ssure patients can diminish perfusion pressure to the anal tissue 
and lead to ischemic ulceration ( 4 – 6 ). 
 We tested the hypothesis that a  “ true oligo-antigenic diet ” — with 
the elimination of cow ’ s milk and its derivatives, wheat, egg, tomato, 
and chocolate from the diet — improves the rate of CAF healing 
compared with a  “ sham- elimination diet ” (both diets combined 
with standard medical treatment). Our results showed that the 
patient group on  “ true-elimination diet ” had a signifi cantly higher 
rate of CAF healing from the fourth week of treatment (52 % vs. 
30 % ), and at the end of the 8 weeks of study they had a frequency 
of cured fi ssures of 69 % vs. 45 % in the group of the patients treated 
with a  “ sham diet. ” Pain score on defecation was also signifi cantly 
lower from the fourth week in the patients on  “ true-elimination 
diet ” than in the controls on  “ sham diet. ” 
 However, it must be noted that the percentage of healed AFs on 
glycerol nitrate treatment reported in the literature (24 – 90 % ) ( 2 ) 
is consistent with the frequency of cured patients we observed in 
our study groups. 
 In the second part of the study, we attempted to demonstrate 
a causal eff ect of FH on the appearance of AF and on anal rest-
ing pressure. Of the 60 patients who received standard medical 
treatment plus  “ true-elimination diet, ” 13 showed AF recurrence 
and severe pain on defecation on cow ’ s milk challenge. Painful 
defecation reappeared very quickly — between 1 and 8 days aft er 
the beginning of the challenge — and AF recurrence prevented 
the conclusion of the 2-week challenge in 10 patients; all 13 
patients showed AFs at the end of the challenge. Aft er adequate 
medical and dietary treatment, none of these patients reacted to 
10
9
8
7
6
5
4
3
2
VA
S 
(0
–
10
)
1
0
Baseline First week Second week
DBPC-positive
patients
DBPC-negative
patients
VAS score:
0=none;10=worst
 Figure 2 .  Visual analog score (VAS) values  (mean  +  s.d.) of pain on defeca-
tion on cow ’ s milk double-blind placebo controlled (DBPC) challenge in 
13 patients positive to the challenge (Group A) and in 47 negative to the 
challenge (Group B).  
 Table 3 .  Part 2 of the study 
  Group 1,  N =13  Group 2,  N =47  P value 
 Anal sphincter resting pressure (mm  Hg) 
  Before challenge  82 ± 7  80 ± 8  Not 
signifi cant 
  At the end of 
challenge 
 99 ± 5  83 ± 7  0.0001 
 Rectal histology 
  IEL number  70 (40 – 120)  30 (10 – 90)  0.0001 
  Lamina propria 
Eosinophil number 
 50 (10 – 90)  20 (10 – 80)  0.0001 
 CAF, chronic and fi ssure; VAS, visual analog score. 
 Mean values ( ± s.d.) of anal sphincter resting pressure before CM challenge and 
at the end of the challenge. Median and range values of lamina propria eosi-
nophils and IEL in the rectal mucosa. Group 1 consisted of patients who became 
symptomatic (recurrence of anal fi ssures) on challenge. Group 2 consisted of 
patients who remained asymptomatic on challenge. 
 Notes: Anal sphincter resting pressure was recorded the day before the begin-
ning of the cow’s milk protein challenge, when all patients were asymptomatic 
and had no anal fi ssure, and was reevaluated at the end of the cow’s milk 
challenge. 
 Normal limits for anal sphincter resting pressure were between 45 and 
70  mm  Hg.  Rectal histology was evaluated at entry to the fi rst part of the study, 
when all patients were symptomatic and had CAF. Intraepithelial lymphocytes 
and lamina propria eosinophils were counted in 10 high-power fi eld — HPF × 40 
(IEL normal limits   <  70 lymphocytes; eosiniphil normal limit  <  60). 
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hypersensitivity to cow ’ s milk proteins. Regarding other pos-
sible pathogenetic mechanisms, referring to the  “ gluten-
sensitivity fi eld ” , we would recall that in experimental model 
gluten was able to determine an increased acetylcholine release 
from the myenteric plexus and muscle hypercontractility in 
DQ-8 mice ( 25 ). 
 On the other hand, the IgE-mediated immunologic assays 
(PRISTs, Skin tests) have a very low accuracy in the diagnosis of 
most gastrointestinal manifestations due to FH ( 26 ), and this can 
be in keeping with the low rate of positive serum-specifi c IgE for 
food antigens that we found in our patients. 
 Furthermore, we did not provide any data on mast cell infi ltra-
tion in the rectal mucosa, nor on the interactions between infl am-
matory and neural cells. It has been demonstrated that mast cells 
have a fundamental role in children with chronic constipation 
due to FH ( 17 ) and, in general, in colon dismotility ( 27 ). How-
ever, our data supported the evidence that mucosal infl ammation 
infl uenced anal resting pressure and underlined a possible role of 
lymphocytes and eosinophil cells. It is interesting to recall that the 
fecal excretion of eosinophil cationic protein has recently been 
suggested as a possible marker of food allergy in patients with 
irritable bowel syndrome-like symptoms ( 18 ), and some experi-
mental data suggest a role for eotaxin — an eosinophil-derived 
cytokine — in gastrointestinal dismotility ( 28 ). 
 In conclusion, our data demonstrated, for the fi rst time, that 
an oligo-antigenic diet combined with medical treatment could 
improve the rate of CAF healing. Moreover, in 20 % of  the patients 
who received medical and dietary treatment, AFs recurred 
on DBPC cow ’ s milk challenge and, to a lesser degree, on wheat 
challenge. Th e ingestion of these foods also increased anal resting 
pressure. 
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the placebo administration. An identical reaction to the chal-
lenge was recorded in the seven patients who were positive to 
the wheat challenge, as regards the time and the severity of the 
clinical reaction. 
 During the cow ’ s milk challenge, anal sphincter resting pressure 
signifi cantly increased from 82 to 99  mm  Hg in all patients who 
reacted with AF recurrence, whereas no signifi cant changes were 
observed in those who did not react to the challenge. At the end 
of the challenge period, the anal resting pressure was  signifi cantly 
higher in patients who were positive to the challenge than in those 
who were negative. 
 Th e patients who were positive to the challenges showed sig-
nifi cantly higher infl ammatory infi ltration in the rectal mucosa 
than the patients who were negative to the challenges. Both 
intraepithelial lymphocytes and lamina propria eosinophils were 
signifi cantly higher in patients who reacted, and about half of 
these subjects had lymphocyte and eosinophil values above the 
normal limits for our laboratory. Th ese fi ndings are in agreement 
with the data recorded in patients with irritable bowel syndrome 
where immune cell infi ltration and activation is considered a 
pivotal mechanism of dismotility ( 20,21 ). Future studies should 
clarify whether the rectal mucosa histology evaluation — estab-
lishing a threshold of infl ammatory cell number — could be use-
ful in identifying the patients with AFs, who would benefi t from 
the elimination diet or not. 
 Th ere are a number of limitations in our study. First, the 
choice of the foods to avoid in the elimination diet was arbi-
trary. We based the diets — “ true diet ” and  “ sham diet ” — on our 
previous experience; for several decades we have studied FH 
and applied this experience in this study design. However, 
it is probable that we underestimated the number of the patients 
with AF due to FB, as many off ending foods could not be 
excluded in the elimination diet prescribed to the patients. Fur-
thermore, all patients received bran and it can contain gluten; 
this could determine symptoms in gluten-sensitive patients. On 
the other hand, it is possible that the patients we studied were 
preselected by their physicians who referred them to the Sur-
gery Department that collaborated with us, a center with expe-
rience in FH. Th is possible selection bias could have increased 
the percentage of AFs due to FH. Consequently, our data do not 
off er a defi nitive conclusion about the real frequency of AF due 
to FH. 
 It is noteworthy that in our study a high percentage of the 
patients suff ered from constipation; although constipation is 
commonly associated to AFs, other studies have reported a 
lower frequency of constipation in subjects with AFs ( 22,23 ). 
 We have not provided evidence of an allergic mechanism in 
the pathogenesis of AFs in the patients we studied, and alterna-
tive hypotheses should be considered. It has been demonstrated 
that the fat content in milk decreased the levels of circulating 
motilin and ghrelin, consequently inducing constipation ( 24 ); 
this could contribute to the appearance of AFs. However, it 
must be said that in our study the challenges were performed 
with capsules containing exclusively cow ’ s milk proteins and 
the reaction to the challenge was rapid; this suggests a  possible 
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 Study Highlights  
 WHAT IS CURRENT KNOWLEDGE 
 3 Chronic constipation in children can be due to food hyper-
sensitivity (FH). One of the pathological mechanisms of 
constipation due to FH is the high resting anal pressure, 
which normalizes on elimination diet. It has been 
demonstrated that resting anal pressure is also elevated 
in patients with anal fi ssure (AF), and this could therefore 
diminish perfusion pressure to the anal tissue and lead to 
ischemic ulceration.  
 3 We hypothesized that an unrecognized FH could be the 
cause of AFs in some percentage of the adult cases; there-
fore, we evaluate the effectiveness of an oligo-antigenic 
diet in the treatment of chronic AFs (CAFs) and search for 
a possible cause – effect relationship between the diet and 
the onset of the AFs. 
 WHAT IS NEW HERE 
 3 The patient group that underwent a  “ true-elimination diet ” 
had a signifi cantly higher rate of CAF healing from the 
fourth week of treatment and at the end of the 8 weeks of 
the study, compared with the control patient group treated 
with a  “ sham diet. ” Pain score on defecation was also 
signifi cantly lower from the fourth week in the patients 
on  “ true-elimination diet ” than in the patients on  “ sham 
diet. ” 
 3 About 20 % of the patients who received standard 
medical treatment plus  “ true-elimination diet, ” showed AF 
recurrence and severe pain on defecation on cow ’ s milk 
challenge. After adequate medical and dietary treatment, 
none of these patients reacted to the placebo administra-
tion. An identical reaction to the challenge was recorded in 
a lower percentage of the patients who were positive to the 
wheat challenge. 
 3 Therefore, our data demonstrated, for the fi rst time, that 
an oligo-antigenic diet combined with medical treatment 
can improve the rate of CAF healing; and if AFs might be 
etiologically related to a FH condition, then it should be 
studied. 
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